Cigna earnings beat by $0.04, revenue topped estimates
On Wednesday, Citi analyst George Kurosawa revised the price target for Manhattan Associates, Inc. (NASDAQ: NASDAQ:MANH), bringing it down to $244 from the previous $303, while maintaining a Neutral rating on the company’s shares. According to InvestingPro data, the stock is currently trading at a significant premium to its Fair Value, with a P/E ratio of 83x and a market capitalization of $18 billion. The adjustment followed Manhattan Associates’ fourth-quarter 2024 earnings report, which presented mixed results influenced by foreign exchange fluctuations and downsizing in the company’s Professional Services segment. This led to a $50 million cut to the calendar year 2025 revenue outlook, factoring in a $20 million impact from currency exchange issues, and bringing growth projections down to 2-3% year-over-year compared to the previously anticipated 9%.
Despite these setbacks, Manhattan Associates experienced a notable increase in net new Remaining Performance Obligations (RPO) quarter-over-quarter excluding foreign exchange impacts, reaching a record high of $127 million, which was $13 million ahead of the guidance. The company maintains strong financial fundamentals, with InvestingPro analysis showing impressive revenue growth of 15.3% over the last twelve months and a "GREAT" overall financial health score. This was attributed to a combination of catching up on previously delayed deals and a robust purchasing environment that persisted into the first quarter, prompting an uplifted CY25 RPO target excluding foreign exchange considerations.
Kurosawa pointed out that while some investors may focus on the strong RPO figures and consider the Professional Services issues as non-core to the long-term cloud strategy, the current financial landscape presents challenges. InvestingPro subscribers have access to 15+ additional exclusive insights about Manhattan Associates, including detailed valuation metrics and growth projections, available in the comprehensive Pro Research Report. The low single-digit revenue growth forecast for CY25 and negative EPS growth pose difficulties in maintaining the stock’s premium valuation. The revised price target of $244 is based on a 42 times multiple of the calendar year 2026 enterprise value to free cash flow, reflecting lower estimates and a reduced premium due to incremental macroeconomic headwinds. Following the report, Manhattan Associates’ stock experienced a roughly 25% decline in after-hours trading.
In other recent news, Manhattan Associates Inc. reported Q4 earnings that surpassed analyst expectations, with adjusted earnings per share of $1.17 and a 7.3% YoY revenue increase to $255.8 million. However, the company’s fiscal 2025 outlook was less than rosy, with a full-year EPS guidance of $4.45-$4.55, falling short of the $4.61 analyst consensus. Conversely, revenue guidance of $1.06-1.07 billion slightly exceeded the $1.04 billion estimate.
Cloud subscription revenue for Q4 saw a significant leap, increasing 26.5% YoY to $90.3 million. The company also reported record bookings, exceeding expectations with remaining performance obligations (RPO) growing 25% YoY to $1.78 billion.
Manhattan Associates also engaged in stock repurchasing, buying back 155,444 shares for $43.5 million during the quarter. The full year saw the company repurchase 986,555 shares, totaling $241.6 million. These are among the recent developments for Manhattan Associates.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.